| Registered number: 12481219 | ||||||||
| FOR THE YEAR ENDED 28/02/2025 | ||||||||
| Prepared By: | ||||||||
| Andrews & O'Shea Limited | ||||||||
| Optima House | ||||||||
| Spindle Way | ||||||||
| Crawley | ||||||||
| West Sussex | ||||||||
| RH101TT | ||||||||
| Indigo Life Sciences Ltd | ||||||||
| ACCOUNTS | ||||||||
| FOR THE YEAR ENDED 28/02/2025 | ||||||||
| DIRECTORS | ||||||||
| REGISTERED OFFICE | ||||||||
| West Sussex | ||||||||
| COMPANY DETAILS | ||||||||
| Private company limited by shares registered in England and Wales, registered number 12481219 | ||||||||
| ACCOUNTANTS | ||||||||
| Andrews & O'Shea Limited | ||||||||
| Optima House | ||||||||
| Spindle Way | ||||||||
| Crawley | ||||||||
| West Sussex | ||||||||
| RH101TT | ||||||||
| Indigo Life Sciences Ltd | ||||||||
| ACCOUNTS | ||||||||
| FOR THEYEARENDED28/02/2025 | ||||||||
| CONTENTS | ||||||||
| Page | ||||||||
| Directors' Report | - | |||||||
| Accountants' Report | - | |||||||
| Statement Of Comprehensive Income | - | |||||||
| Balance Sheet | 3 | |||||||
| Notes To The Accounts | 4 | |||||||
| The following do not form part of the statutory financial statements: | ||||||||
| Trading And Profit And Loss Account | - | |||||||
| Profit And Loss Account Summaries | - | |||||||
| Indigo Life Sciences Ltd | ||||||||
| BALANCE SHEET AT | ||||||||||
| 2025 | 2024 | |||||||||
| Notes | £ | £ | ||||||||
| FIXED ASSETS | ||||||||||
| Tangible assets | 3 | |||||||||
| CURRENT ASSETS | ||||||||||
| Debtors | 4 | |||||||||
| Cash at bank and in hand | ||||||||||
| 11,500 | 28,962 | |||||||||
| CREDITORS: Amounts falling due within one year | 5 | |||||||||
| NET CURRENT (LIABILITIES) / ASSETS | ( | 18,348 | ||||||||
| TOTAL ASSETS LESS CURRENT LIABILITIES | ( | |||||||||
| CAPITAL AND RESERVES | ||||||||||
| Called up share capital | 6 | |||||||||
| Profit and loss account | (14,388) | 21,508 | ||||||||
| SHAREHOLDERS' FUNDS | ( | |||||||||
| Approved by the board on | ||||||||||
| ............................. | ||||||||||
| Director | ||||||||||
| Indigo Life Sciences Ltd | ||||||||
| NOTES TO THE ACCOUNTS | ||||||||||
| FOR THE YEAR ENDED 28/02/2025 | ||||||||||
| 1. ACCOUNTING POLICIES |
| 1a. Basis Of Accounting | ||||||||
| The accounts have been prepared under the historical cost convention. | ||||||||
| The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . | ||||||||
| 1b. Depreciation | ||||||||
| Plant and Machinery | straight line 25% | |||||||
| Fixtures and Fittings | straight line 25% | |||||||
| Equipment | straight line 25% | |||||||
| 1c. Pension Costs | ||||||||
| The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. | ||||||||
| 2. EMPLOYEES | ||||||
| 2025 | 2024 | |||||
| No. | No. | |||||
| Average number of employees | 4 | |||||
| Indigo Life Sciences Ltd | ||||||||
| 3. TANGIBLE FIXED ASSETS | ||||||||
| Plant and | Fixtures | |||||||
| Machinery | and Fittings | Equipment | Total | |||||
| £ | £ | £ | £ | |||||
| Cost | ||||||||
| At 01/03/2024 | 2,477 | 1,455 | 6,469 | 10,401 | ||||
| At 28/02/2025 | 2,477 | 1,455 | 6,469 | 10,401 | ||||
| Depreciation | ||||||||
| At 01/03/2024 | 1,239 | 720 | 5,182 | 7,141 | ||||
| For the year | 619 | 364 | 1,287 | 2,270 | ||||
| At 28/02/2025 | 1,858 | 1,084 | 6,469 | 9,411 | ||||
| Net Book Amounts | ||||||||
| At 28/02/2025 | 990 | |||||||
| At 29/02/2024 | 3,260 | |||||||
| 4. DEBTORS | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Amounts falling due within one year | ||||||||
| UK corporation tax | 3,734 | - | ||||||
| 3,734 | - | |||||||
| 5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
| 2025 | 2024 | |||||||
| £ | £ | |||||||
| UK corporation tax | - | 3,484 | ||||||
| VAT | 6,226 | 5,080 | ||||||
| Salaries and wages control | - | 1 | ||||||
| Directors current account Charlie | 11,038 | 38 | ||||||
| Directors current account Eric | 7,714 | 211 | ||||||
| Accruals | 1,800 | 1,800 | ||||||
| 26,778 | 10,614 | |||||||
| Indigo Life Sciences Ltd | ||||||||
| 6. SHARE CAPITAL | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Allotted, issued and fully paid: | ||||||||
| 100 | ||||||||
| 100 | 100 | |||||||